Remove 2025 Remove Degenerative Disc Disease Remove Spine
article thumbnail

Spinal Stabilization Technologies™ Announces Enrollment of First U.S. Patient in IDE Trial for PerQdisc™ Nucleus Replacement Device

OrthoSpineNews

Spine Surgeon Dr. Frank Phillips Joins SST Board of Directors SAN ANTONIO, March 3, 2025 /PRNewswire/ — Spinal Stabilization Technologies, LLC (SST) has announced a significant milestone in its mission to revolutionize spinal care: the enrollment of the first U.S. Pierce Nunley completes the first U.S. PerQdisc Surgery.

article thumbnail

Study Confirms Significant Clinical Benefit of Neo Medical’s Force Control Technology™ in Spinal Fusion Surgery

OrthoSpineNews

Our goal is to move spine surgery beyond the limits of legacy systems, reimagining treatment processes to make them safer, more efficient, and more effective for every patient. This seamless integration is intended to provide a personalized and effective approach to spine surgery, which enhances patient care and surgical efficiency.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Phase 2 Trial of BRTX-100 in cLDD Continues to Generate Positive Preliminary Blinded Data

OrthoSpineNews

May 13, 2025 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. We have commenced a Phase 2 clinical trial using BRTX-100 to treat chronic lower back pain arising from degenerative disc disease. MELVILLE, N.Y.,

article thumbnail

Spine BioPharma, Inc. to Present at Biotech Showcase 2025

OrthoSpineNews

January 7, 2025, NEW YORK–( BUSINESS WIRE )–Spine BioPharma, Inc., January 7, 2025, NEW YORK–( BUSINESS WIRE )–Spine BioPharma, Inc., SB-01 modulates TGF-Beta concentration, without eliminating it, mitigating the negative downstream effects.

article thumbnail

Aurora Spine Corporation Announces Completion of Enrollment in Groundbreaking REFINE Study: First Prospective, Multi-Center, Multi-Specialty Study on Lumbar Interlaminar Fusion 

OrthoSpineNews

The results will be presented at the American Society of Pain and Neuroscience (ASPN) annual conference in July 2025, spotlighting Aurora Spines commitment to evidence-based innovation. We are incredibly proud to reach this milestone, said Trent Northcutt, President and CEO of Aurora Spine. CARLSBAD, Calif., CARLSBAD, Calif.,

article thumbnail

Global Spine, MIS and VCF Markets to Reach $38B by 2031, Fueled by Robotic Surgery, MIS Growth, and Next-Gen Implants – iData Research

OrthoSpineNews

Global Spine and VCF Market by Segment 2024 – 2031 – iData Research (CNW Group/iData Research Inc.) “With spinal disorders like degenerative disc disease and stenosis becoming more prevalent, especially among aging populations, spine device companies need precise, actionable intelligence, ” said Dr. .

article thumbnail

BioRestorative Reports Compelling Preliminary Data for FDA-Fast-Tracked BRTX-100 – an Autologous Stem Cell Therapy to Treat Chronic Lumbar Disc Disease

OrthoSpineNews

June 13, 2025 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. This data was shared at the prestigious ISSCR 2025 Annual Meeting in Hong Kong by Francisco Silva, Vice President of Research and Development. We have also obtained U.S.